Baxter International stock falls 4.16 percent on the NYSE

Published on 10/20/2026 at 18:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Evercore set a USD 32.00 target on October 7, 2026. Baxter International stock costs EUR 21.40 on October 20, 2026, down 4.16 percent on NYSE.

Analyst target and reporting date

Evercore ISI listed a USD 32.00 target for Baxter International on October 7, 2026.
Second-quarter 2026 revenue reached USD 2.96 billion, up 5.30 percent year over year.
Baxter International stock costs EUR 21.40 at Lang & Schwarz on October 20, 2026 at 6:47 p.m. CEST, down 4.16 percent versus the NYSE prior close.
Baxter will discuss third-quarter 2026 results on October 29, 2026.

Redaktionelles Foto des NYSE-Handelsparkett mit Healthcare-Kursdiagrammen auf Großleinwänden — Becton Dickinson NYSE Börsenparkett mit Healthcare Sektor Kursdiagrammen auf Screens, Aktie US0718131099, Illustration mit AI erstellt.

Baxter International (ISIN US0718131099) fell 4.16 percent on the NYSE on October 20, 2026, moving from USD 24.99 to USD 23.95. On October 7, 2026, MarketScreener listed an Evercore ISI target of USD 32.00, up from USD 24.00. That target is 33.61 percent above the NYSE price of USD 23.95. After hours, Baxter was trading at EUR 21.40 at Lang & Schwarz on October 20, 2026 at 6:47 p.m. CEST.

Revenue growth sets the latest baseline

Baxter's second-quarter 2026 revenue reached USD 2.96 billion, up 5.30 percent from the same period a year earlier. The quarter's adjusted earnings per share were USD 0.56, compared with a USD 0.37 consensus estimate, according to MarketBeat on October 7, 2026. Revenue also exceeded the USD 2.80 billion consensus estimate, giving investors a quantified comparison before the next report.

Stock sits below the yearly high

On the NYSE, Baxter last traded at USD 23.95 on October 20, 2026 at 12:55 p.m. EDT, with volume of 7,575,412 shares. The USD 15.73 to USD 30.00 52-week range places the stock 20.17 percent below its high and 52.32 percent above its low. The stock's year-to-date performance was plus 30.77 percent as of October 19, 2026.

Results date and valuation matter

Baxter's market capitalization was USD 12.4 billion on October 20, 2026. The company said on October 7, 2026 that it would discuss third-quarter 2026 results on October 29, 2026, at 7:30 a.m. Central Time, in its investor release.

Comparison with peers

Baxter International: down 4.16 percent, market capitalization USD 12.4 billion, October 20, 2026. Becton, Dickinson and Company (NYSE, USD): up 1.19 percent, P/E 58.14, market capitalization USD 52.6 billion, October 20, 2026. Abbott Laboratories (NYSE, USD): down 0.82 percent, P/E 33.15, market capitalization USD 178.6 billion, October 20, 2026.

What the next report will test

The October 29 reporting date gives the revenue trend a near-term checkpoint. The contrast between USD 2.96 billion of second-quarter revenue and the USD 32.00 Evercore ISI target leaves both operating execution and valuation in view.

After hours, Baxter International was trading at EUR 21.40 at Lang & Schwarz on October 20, 2026 at 6:47 p.m. CEST; the NYSE move was down 4.16 percent versus the prior close of October 19, 2026 at USD 24.99. The further course of trading is shown by the continuously updated real-time quote of Baxter International stock.